A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among older adults

M Baay, K Bollaerts, T Verstraeten - Vaccine, 2018 - Elsevier
Introduction New adjuvants have been developed to improve the efficacy of vaccines and for
dose-sparing capacity and may overcome immuno senescence in the elderly. We reviewed …

Perspectives on vaccine development for the elderly

E Oviedo-Orta, CKF Li, R Rappuoli - Current Opinion in Immunology, 2013 - Elsevier
Highlights•Immune dysregulation is associated to the aging process.•Impaired immune
responses in the elderly do not constitute immunodeficiencies but selective states of …

An old problem with new solutions: strategies to improve vaccine efficacy in the elderly

MR Bell, MA Kutzler - Advanced drug delivery reviews, 2022 - Elsevier
Vaccination is the most effective measure to protect against infections. However, with
increasing age, there is a progressive decline in the ability of the immune system to both …

Precision vaccine adjuvants for older adults: a scoping review

E Nanishi, A Angelidou, C Rotman… - Clinical Infectious …, 2022 - academic.oup.com
Older adults, defined as those≥ 60 years of age, are a growing population vulnerable to
infections including severe acute respiratory syndrome coronavirus 2. Although …

Adjuvant strategies to improve vaccination of the elderly population

B Weinberger - Current opinion in pharmacology, 2018 - Elsevier
Highlights•Most current vaccines are less immunogenic and efficient in the older
population.•New adjuvants have improved vaccination success for several …

Efficacy and safety of vaccinations in geriatric patients: a literature review

T Ciarambino, P Crispino, P Buono, V Giordano… - Vaccines, 2023 - mdpi.com
With the progressive lengthening of the average age of the population, especially in some
countries such as Italy, vaccination of the elderly is a fixed point on which most of the public …

Insights into vaccines for elderly individuals: from the impacts of immunosenescence to delivery strategies

Y Hou, M Chen, Y Bian, Y Hu, J Chuan, L Zhong, Y Zhu… - npj Vaccines, 2024 - nature.com
Immunosenescence increases the risk and severity of diseases in elderly individuals and
leads to impaired vaccine-induced immunity. With aging of the global population and the …

[HTML][HTML] Balancing the efficacy and safety of vaccines in the elderly

IJ Amanna - Open Longevity Science, 2012 - ncbi.nlm.nih.gov
With advances in global health care, ageing populations are expected to grow worldwide
throughout the 21 st century. Increased lifespan is a testament to modern medical and social …

Immunosenescence and novel vaccination strategies for the elderly

MG Dorrington, DME Bowdish - Frontiers in immunology, 2013 - frontiersin.org
Vaccination remains the most effective prophylactic intervention for infectious disease in the
healthcare professional's toolkit. However, the efficacy and effectiveness of vaccines …

[HTML][HTML] Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22–23 March 2017

MT Aguado, J Barratt, JR Beard, BB Blomberg… - Vaccine, 2018 - Elsevier
Many industrialized countries have implemented routine immunization policies for older
adults, but similar strategies have not been widely implemented in low-and middle-income …